-
WW International Shares Jump On BCBS Michigan's Revised Authorization For Wegovy, Other Weight Loss Drugs
Friday, September 22, 2023 - 4:25pm | 565Read More...Shares of WW International Inc (NASDAQ:WW) spiked as much as 15% on Friday after Blue Cross Blue Shield of Michigan and Blue Care Network announced changes to the prior authorization coverage criteria for certain brand-name weight loss medications. What Happened: Starting Oct. 1, Blue Cross Blue...
-
Exclusive: Orexigen Therapeutics Execs Talk Contrave And The Stock's Roller-Coaster Ride
Tuesday, May 2, 2017 - 12:17pm | 1485Read More...Meet Orexigen Therapeutics, Inc. (NASDAQ: OREX), a micro-cap biopharmaceutical company delivering one of the strongest stock market performances of 2017 so far. After losing almost 90 percent of its value over 2016, shares have recuperated more than 80 percent this year. Benzinga recently spoke...
-
Orexigen Shares Up 14% After Commercialization, Distribution Deal With Valeant Canada
Tuesday, August 30, 2016 - 9:49am | 346Read More...Orexigen Therapeutics, Inc. (NASDAQ: OREX) and Valeant Canada, a subsidiary of Valeant Pharmaceuticals Intl Inc (NYSE: VRX), struck an agreement on commercialization and distributorship for Contrave. Following the news, Orexigen traded up by more than 12 percent in the pre-market trading. Orexigen...
-
Orexigen Up, Then Steeply Down Following Contrave U.S. Rights Agreement
Tuesday, March 15, 2016 - 12:10pm | 274Read More...Orexigen Therapeutics, Inc. (NASDAQ: OREX) spiked almost 3 percent to $0.81 early Tuesday, but quickly plummeted more than 6 percent. The volatility comes on back of news that the pharmaceutical company will be acquiring Contrave®, the "market leading national branded prescription...
-
Leerink Comments On Orexigen Therapeutics, Says Current Projections Could Prove To Be 'Conservative'
Wednesday, March 4, 2015 - 1:01pm | 110Read More...In a report published Wednesday, Leerink analyst Paul Matteis commented on Orexigen Therapeutics, Inc. (NASDAQ: OREX) and wrote that following a positive opinion from the CHMP, the company expects a final opinion from the EMA on the Mysimba (Contrave) marketing authorization application. Matteis...
-
JP Morgan Upgrades Orexigen Therapeutics to Overweight
Thursday, June 28, 2012 - 2:23pm | 388Read More...Orexigen Therapeutics (NASDAQ: OREX) was upgraded from Neutral to Overweight with a $10 price target by J.P. Morgan on Thursday following FDA approval of the drug Belviq (lorcaserin). Arena Pharmaceuticals (NASDAQ: ARNA) scored a big hit this week after this decision to approve the obesity drug...
-
Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?
Thursday, May 31, 2012 - 12:52pm | 1252Read More...Dear Vivus (NASDAQ: VVUS) investors: You are paying $2.5 billion for a company with zero profits in a market space valued at only $3.5 billion annually. Yes, the FDA advisory committee recommended Qnexa be granted approval in a 20-to-2 vote, but remember that Provenge had a unanimous safety vote...
-
Afternoon Trade: Top and Bottom Five Percentage Gainers (MSSR, AIB, HEAT, COOL, OREX, AMIE, JGBO, HRZ, DGW, RVSN)
Monday, April 4, 2011 - 2:13pm | 390Read More...The market was quiet for most of the morning but has just recently begun to come under some selling pressure. All three major indices are now sitting in negative territory. The current top 5% gainers and losers in the market are: Best 1) McCormick & Schmick's Seafood Restaurants (NASDAQ:...
-
Mid-Day Top-5 and Bottom-5 Percentage Gainers (MSSR, CRYP, COOL, OREX, AEN, AMIE, DGW, HRZ, RVSN, TPI)
Monday, April 4, 2011 - 1:40pm | 396Read More...After opening slightly to the upside, the major indices have been meandering around neutral territory for most of the day. Traders are seemingly unsure as they assess the continuing rise in oil and commodities and evaluate the potential impact on the economy. Here are the five best/worst performers...
-
Morning Trade: Top And Bottom Five Percentage Gainers (MSSR, OREX, TFCO, VVUS, CSCD, AMIE, DGW, AFFM, RVSN, IBCPO)
Monday, April 4, 2011 - 11:23am | 402Read More...The market opened slightly to the upside this morning with the Dow Jones Industrial Average, S&P 500, and NASDAQ Composite all posting slight gains. The market is looking to build on last week's positive momentum, which saw positive economic numbers in many areas including the Jobs Report and...
